Royalty Pharma
Price & Volume
Stats
See moreOpen | $44.70 |
Previous Close | $44.65 |
Day Range | $43.98-$44.90 |
52W Range | $29.12-$44.92 |
Market Cap | $26B |
Shares Short | 27M |
Financials
See moreRevenue (12 Mos) | $2.3B |
Revenue Growth (YoY) | 7.9% |
Gross Profit (12 Mos) | $2.5B |
Diluted EPS | $1.75 |
News
See moreYahoo Finance • last month
Royalty Pharma buys remaining royalty interest in Roche drug Evrysdi
Yahoo Finance • last month
Royalty Pharma Acquires Remaining Royalty Interest in Roche’s Evrysdi for $240 Million and Potential Milestones
Yahoo Finance • 2 months ago
Caledonia (Private) Investments Doubles Down on Coursera Stock: Is it Time to Buy?
Yahoo Finance • 2 months ago
Royalty Pharma and Denali Therapeutics Announce $275 Million Royalty Funding Agreement
About
CEO | Mr. Pablo Legorreta |
CFO | Mr. Terrance P. Coyne |
Address | 110 East 59th Street, New York, NY, United States, 10022 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 0 |
